It is also possible that if LRRC25 enhances the degradation of AD-related enzymes such as BACE1 or γ-secretase, then we expect complete abrogation of Aβ generation and therefore amyloid plaque formation. This evidence concerns the gene BACE1 and Alzheimer disease.